{
 "cells": [
  {
   "cell_type": "markdown",
   "id": "e8b9035f",
   "metadata": {},
   "source": [
    "# BatchLegal Preprocessing"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "6d4e164f",
   "metadata": {},
   "source": [
    "***Base***: preproc final (from Chris):\n",
    "- Adjusted preprocessing steps: sentence tokenization and multiple lemmatizing steps.\n",
    "- Changed from CountVectorizer to TfidfVectorizer\n",
    "- Now spacy is used for lemmatization"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1,
   "id": "7ffe11a2",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Requirement already satisfied: spacy in /Users/axelpichler/.pyenv/versions/3.8.13/envs/lewagon/lib/python3.8/site-packages (3.3.0)\n",
      "Requirement already satisfied: spacy-legacy<3.1.0,>=3.0.9 in /Users/axelpichler/.pyenv/versions/3.8.13/envs/lewagon/lib/python3.8/site-packages (from spacy) (3.0.9)\n",
      "Requirement already satisfied: tqdm<5.0.0,>=4.38.0 in /Users/axelpichler/.pyenv/versions/3.8.13/envs/lewagon/lib/python3.8/site-packages (from spacy) (4.62.3)\n",
      "Requirement already satisfied: cymem<2.1.0,>=2.0.2 in /Users/axelpichler/.pyenv/versions/3.8.13/envs/lewagon/lib/python3.8/site-packages (from spacy) (2.0.6)\n",
      "Requirement already satisfied: blis<0.8.0,>=0.4.0 in /Users/axelpichler/.pyenv/versions/3.8.13/envs/lewagon/lib/python3.8/site-packages (from spacy) (0.7.7)\n",
      "Requirement already satisfied: packaging>=20.0 in /Users/axelpichler/.pyenv/versions/3.8.13/envs/lewagon/lib/python3.8/site-packages (from spacy) (21.3)\n",
      "Requirement already satisfied: pydantic!=1.8,!=1.8.1,<1.9.0,>=1.7.4 in /Users/axelpichler/.pyenv/versions/3.8.13/envs/lewagon/lib/python3.8/site-packages (from spacy) (1.8.2)\n",
      "Requirement already satisfied: langcodes<4.0.0,>=3.2.0 in /Users/axelpichler/.pyenv/versions/3.8.13/envs/lewagon/lib/python3.8/site-packages (from spacy) (3.3.0)\n",
      "Requirement already satisfied: wasabi<1.1.0,>=0.9.1 in /Users/axelpichler/.pyenv/versions/3.8.13/envs/lewagon/lib/python3.8/site-packages (from spacy) (0.9.1)\n",
      "Requirement already satisfied: catalogue<2.1.0,>=2.0.6 in /Users/axelpichler/.pyenv/versions/3.8.13/envs/lewagon/lib/python3.8/site-packages (from spacy) (2.0.7)\n",
      "Requirement already satisfied: requests<3.0.0,>=2.13.0 in /Users/axelpichler/.pyenv/versions/3.8.13/envs/lewagon/lib/python3.8/site-packages (from spacy) (2.27.1)\n",
      "Requirement already satisfied: preshed<3.1.0,>=3.0.2 in /Users/axelpichler/.pyenv/versions/3.8.13/envs/lewagon/lib/python3.8/site-packages (from spacy) (3.0.6)\n",
      "Requirement already satisfied: typer<0.5.0,>=0.3.0 in /Users/axelpichler/.pyenv/versions/3.8.13/envs/lewagon/lib/python3.8/site-packages (from spacy) (0.4.1)\n",
      "Requirement already satisfied: jinja2 in /Users/axelpichler/.pyenv/versions/3.8.13/envs/lewagon/lib/python3.8/site-packages (from spacy) (3.0.3)\n",
      "Requirement already satisfied: spacy-loggers<2.0.0,>=1.0.0 in /Users/axelpichler/.pyenv/versions/3.8.13/envs/lewagon/lib/python3.8/site-packages (from spacy) (1.0.2)\n",
      "Requirement already satisfied: numpy>=1.15.0 in /Users/axelpichler/.pyenv/versions/3.8.13/envs/lewagon/lib/python3.8/site-packages (from spacy) (1.18.5)\n",
      "Requirement already satisfied: setuptools in /Users/axelpichler/.pyenv/versions/3.8.13/envs/lewagon/lib/python3.8/site-packages (from spacy) (56.0.0)\n",
      "Requirement already satisfied: murmurhash<1.1.0,>=0.28.0 in /Users/axelpichler/.pyenv/versions/3.8.13/envs/lewagon/lib/python3.8/site-packages (from spacy) (1.0.7)\n",
      "Requirement already satisfied: srsly<3.0.0,>=2.4.3 in /Users/axelpichler/.pyenv/versions/3.8.13/envs/lewagon/lib/python3.8/site-packages (from spacy) (2.4.3)\n",
      "Requirement already satisfied: pathy>=0.3.5 in /Users/axelpichler/.pyenv/versions/3.8.13/envs/lewagon/lib/python3.8/site-packages (from spacy) (0.6.1)\n",
      "Requirement already satisfied: thinc<8.1.0,>=8.0.14 in /Users/axelpichler/.pyenv/versions/3.8.13/envs/lewagon/lib/python3.8/site-packages (from spacy) (8.0.16)\n",
      "Requirement already satisfied: pyparsing!=3.0.5,>=2.0.2 in /Users/axelpichler/.pyenv/versions/3.8.13/envs/lewagon/lib/python3.8/site-packages (from packaging>=20.0->spacy) (3.0.6)\n",
      "Requirement already satisfied: smart-open<6.0.0,>=5.0.0 in /Users/axelpichler/.pyenv/versions/3.8.13/envs/lewagon/lib/python3.8/site-packages (from pathy>=0.3.5->spacy) (5.2.1)\n",
      "Requirement already satisfied: typing-extensions>=3.7.4.3 in /Users/axelpichler/.pyenv/versions/3.8.13/envs/lewagon/lib/python3.8/site-packages (from pydantic!=1.8,!=1.8.1,<1.9.0,>=1.7.4->spacy) (4.2.0)\n",
      "Requirement already satisfied: urllib3<1.27,>=1.21.1 in /Users/axelpichler/.pyenv/versions/3.8.13/envs/lewagon/lib/python3.8/site-packages (from requests<3.0.0,>=2.13.0->spacy) (1.26.7)\n",
      "Requirement already satisfied: certifi>=2017.4.17 in /Users/axelpichler/.pyenv/versions/3.8.13/envs/lewagon/lib/python3.8/site-packages (from requests<3.0.0,>=2.13.0->spacy) (2021.10.8)\n",
      "Requirement already satisfied: idna<4,>=2.5 in /Users/axelpichler/.pyenv/versions/3.8.13/envs/lewagon/lib/python3.8/site-packages (from requests<3.0.0,>=2.13.0->spacy) (3.3)\n",
      "Requirement already satisfied: charset-normalizer~=2.0.0 in /Users/axelpichler/.pyenv/versions/3.8.13/envs/lewagon/lib/python3.8/site-packages (from requests<3.0.0,>=2.13.0->spacy) (2.0.10)\n",
      "Requirement already satisfied: click<9.0.0,>=7.1.1 in /Users/axelpichler/.pyenv/versions/3.8.13/envs/lewagon/lib/python3.8/site-packages (from typer<0.5.0,>=0.3.0->spacy) (8.0.3)\n",
      "Requirement already satisfied: MarkupSafe>=2.0 in /Users/axelpichler/.pyenv/versions/3.8.13/envs/lewagon/lib/python3.8/site-packages (from jinja2->spacy) (2.0.1)\n"
     ]
    }
   ],
   "source": [
    "!pip install -U spacy"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "id": "c8ef7567",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Collecting en-core-web-sm==3.3.0\n",
      "  Downloading https://github.com/explosion/spacy-models/releases/download/en_core_web_sm-3.3.0/en_core_web_sm-3.3.0-py3-none-any.whl (12.8 MB)\n",
      "\u001b[2K     \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m12.8/12.8 MB\u001b[0m \u001b[31m14.3 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0m00:01\u001b[0m00:01\u001b[0m\n",
      "\u001b[?25hRequirement already satisfied: spacy<3.4.0,>=3.3.0.dev0 in /Users/axelpichler/.pyenv/versions/3.8.13/envs/lewagon/lib/python3.8/site-packages (from en-core-web-sm==3.3.0) (3.3.0)\n",
      "Requirement already satisfied: murmurhash<1.1.0,>=0.28.0 in /Users/axelpichler/.pyenv/versions/3.8.13/envs/lewagon/lib/python3.8/site-packages (from spacy<3.4.0,>=3.3.0.dev0->en-core-web-sm==3.3.0) (1.0.7)\n",
      "Requirement already satisfied: pydantic!=1.8,!=1.8.1,<1.9.0,>=1.7.4 in /Users/axelpichler/.pyenv/versions/3.8.13/envs/lewagon/lib/python3.8/site-packages (from spacy<3.4.0,>=3.3.0.dev0->en-core-web-sm==3.3.0) (1.8.2)\n",
      "Requirement already satisfied: spacy-legacy<3.1.0,>=3.0.9 in /Users/axelpichler/.pyenv/versions/3.8.13/envs/lewagon/lib/python3.8/site-packages (from spacy<3.4.0,>=3.3.0.dev0->en-core-web-sm==3.3.0) (3.0.9)\n",
      "Requirement already satisfied: cymem<2.1.0,>=2.0.2 in /Users/axelpichler/.pyenv/versions/3.8.13/envs/lewagon/lib/python3.8/site-packages (from spacy<3.4.0,>=3.3.0.dev0->en-core-web-sm==3.3.0) (2.0.6)\n",
      "Requirement already satisfied: typer<0.5.0,>=0.3.0 in /Users/axelpichler/.pyenv/versions/3.8.13/envs/lewagon/lib/python3.8/site-packages (from spacy<3.4.0,>=3.3.0.dev0->en-core-web-sm==3.3.0) (0.4.1)\n",
      "Requirement already satisfied: setuptools in /Users/axelpichler/.pyenv/versions/3.8.13/envs/lewagon/lib/python3.8/site-packages (from spacy<3.4.0,>=3.3.0.dev0->en-core-web-sm==3.3.0) (56.0.0)\n",
      "Requirement already satisfied: spacy-loggers<2.0.0,>=1.0.0 in /Users/axelpichler/.pyenv/versions/3.8.13/envs/lewagon/lib/python3.8/site-packages (from spacy<3.4.0,>=3.3.0.dev0->en-core-web-sm==3.3.0) (1.0.2)\n",
      "Requirement already satisfied: jinja2 in /Users/axelpichler/.pyenv/versions/3.8.13/envs/lewagon/lib/python3.8/site-packages (from spacy<3.4.0,>=3.3.0.dev0->en-core-web-sm==3.3.0) (3.0.3)\n",
      "Requirement already satisfied: langcodes<4.0.0,>=3.2.0 in /Users/axelpichler/.pyenv/versions/3.8.13/envs/lewagon/lib/python3.8/site-packages (from spacy<3.4.0,>=3.3.0.dev0->en-core-web-sm==3.3.0) (3.3.0)\n",
      "Requirement already satisfied: wasabi<1.1.0,>=0.9.1 in /Users/axelpichler/.pyenv/versions/3.8.13/envs/lewagon/lib/python3.8/site-packages (from spacy<3.4.0,>=3.3.0.dev0->en-core-web-sm==3.3.0) (0.9.1)\n",
      "Requirement already satisfied: tqdm<5.0.0,>=4.38.0 in /Users/axelpichler/.pyenv/versions/3.8.13/envs/lewagon/lib/python3.8/site-packages (from spacy<3.4.0,>=3.3.0.dev0->en-core-web-sm==3.3.0) (4.62.3)\n",
      "Requirement already satisfied: requests<3.0.0,>=2.13.0 in /Users/axelpichler/.pyenv/versions/3.8.13/envs/lewagon/lib/python3.8/site-packages (from spacy<3.4.0,>=3.3.0.dev0->en-core-web-sm==3.3.0) (2.27.1)\n",
      "Requirement already satisfied: pathy>=0.3.5 in /Users/axelpichler/.pyenv/versions/3.8.13/envs/lewagon/lib/python3.8/site-packages (from spacy<3.4.0,>=3.3.0.dev0->en-core-web-sm==3.3.0) (0.6.1)\n",
      "Requirement already satisfied: numpy>=1.15.0 in /Users/axelpichler/.pyenv/versions/3.8.13/envs/lewagon/lib/python3.8/site-packages (from spacy<3.4.0,>=3.3.0.dev0->en-core-web-sm==3.3.0) (1.18.5)\n",
      "Requirement already satisfied: preshed<3.1.0,>=3.0.2 in /Users/axelpichler/.pyenv/versions/3.8.13/envs/lewagon/lib/python3.8/site-packages (from spacy<3.4.0,>=3.3.0.dev0->en-core-web-sm==3.3.0) (3.0.6)\n",
      "Requirement already satisfied: packaging>=20.0 in /Users/axelpichler/.pyenv/versions/3.8.13/envs/lewagon/lib/python3.8/site-packages (from spacy<3.4.0,>=3.3.0.dev0->en-core-web-sm==3.3.0) (21.3)\n",
      "Requirement already satisfied: blis<0.8.0,>=0.4.0 in /Users/axelpichler/.pyenv/versions/3.8.13/envs/lewagon/lib/python3.8/site-packages (from spacy<3.4.0,>=3.3.0.dev0->en-core-web-sm==3.3.0) (0.7.7)\n",
      "Requirement already satisfied: thinc<8.1.0,>=8.0.14 in /Users/axelpichler/.pyenv/versions/3.8.13/envs/lewagon/lib/python3.8/site-packages (from spacy<3.4.0,>=3.3.0.dev0->en-core-web-sm==3.3.0) (8.0.16)\n",
      "Requirement already satisfied: catalogue<2.1.0,>=2.0.6 in /Users/axelpichler/.pyenv/versions/3.8.13/envs/lewagon/lib/python3.8/site-packages (from spacy<3.4.0,>=3.3.0.dev0->en-core-web-sm==3.3.0) (2.0.7)\n",
      "Requirement already satisfied: srsly<3.0.0,>=2.4.3 in /Users/axelpichler/.pyenv/versions/3.8.13/envs/lewagon/lib/python3.8/site-packages (from spacy<3.4.0,>=3.3.0.dev0->en-core-web-sm==3.3.0) (2.4.3)\n",
      "Requirement already satisfied: pyparsing!=3.0.5,>=2.0.2 in /Users/axelpichler/.pyenv/versions/3.8.13/envs/lewagon/lib/python3.8/site-packages (from packaging>=20.0->spacy<3.4.0,>=3.3.0.dev0->en-core-web-sm==3.3.0) (3.0.6)\n",
      "Requirement already satisfied: smart-open<6.0.0,>=5.0.0 in /Users/axelpichler/.pyenv/versions/3.8.13/envs/lewagon/lib/python3.8/site-packages (from pathy>=0.3.5->spacy<3.4.0,>=3.3.0.dev0->en-core-web-sm==3.3.0) (5.2.1)\n",
      "Requirement already satisfied: typing-extensions>=3.7.4.3 in /Users/axelpichler/.pyenv/versions/3.8.13/envs/lewagon/lib/python3.8/site-packages (from pydantic!=1.8,!=1.8.1,<1.9.0,>=1.7.4->spacy<3.4.0,>=3.3.0.dev0->en-core-web-sm==3.3.0) (4.2.0)\n",
      "Requirement already satisfied: certifi>=2017.4.17 in /Users/axelpichler/.pyenv/versions/3.8.13/envs/lewagon/lib/python3.8/site-packages (from requests<3.0.0,>=2.13.0->spacy<3.4.0,>=3.3.0.dev0->en-core-web-sm==3.3.0) (2021.10.8)\n",
      "Requirement already satisfied: charset-normalizer~=2.0.0 in /Users/axelpichler/.pyenv/versions/3.8.13/envs/lewagon/lib/python3.8/site-packages (from requests<3.0.0,>=2.13.0->spacy<3.4.0,>=3.3.0.dev0->en-core-web-sm==3.3.0) (2.0.10)\n",
      "Requirement already satisfied: idna<4,>=2.5 in /Users/axelpichler/.pyenv/versions/3.8.13/envs/lewagon/lib/python3.8/site-packages (from requests<3.0.0,>=2.13.0->spacy<3.4.0,>=3.3.0.dev0->en-core-web-sm==3.3.0) (3.3)\n",
      "Requirement already satisfied: urllib3<1.27,>=1.21.1 in /Users/axelpichler/.pyenv/versions/3.8.13/envs/lewagon/lib/python3.8/site-packages (from requests<3.0.0,>=2.13.0->spacy<3.4.0,>=3.3.0.dev0->en-core-web-sm==3.3.0) (1.26.7)\n",
      "Requirement already satisfied: click<9.0.0,>=7.1.1 in /Users/axelpichler/.pyenv/versions/3.8.13/envs/lewagon/lib/python3.8/site-packages (from typer<0.5.0,>=0.3.0->spacy<3.4.0,>=3.3.0.dev0->en-core-web-sm==3.3.0) (8.0.3)\n",
      "Requirement already satisfied: MarkupSafe>=2.0 in /Users/axelpichler/.pyenv/versions/3.8.13/envs/lewagon/lib/python3.8/site-packages (from jinja2->spacy<3.4.0,>=3.3.0.dev0->en-core-web-sm==3.3.0) (2.0.1)\n",
      "\u001b[33mWARNING: There was an error checking the latest version of pip.\u001b[0m\u001b[33m\n",
      "\u001b[0m\u001b[38;5;2m✔ Download and installation successful\u001b[0m\n",
      "You can now load the package via spacy.load('en_core_web_sm')\n"
     ]
    }
   ],
   "source": [
    "!python -m spacy download en_core_web_sm"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "id": "d5e5bdcf",
   "metadata": {},
   "outputs": [],
   "source": [
    "#Imports\n",
    "\n",
    "import pandas as pd\n",
    "import string\n",
    "from nltk.tokenize import word_tokenize\n",
    "from nltk.corpus import stopwords \n",
    "from nltk.collocations import *\n",
    "\n",
    "import spacy\n",
    "\n",
    "from sklearn.feature_extraction.text import TfidfVectorizer\n",
    "from sklearn.decomposition import LatentDirichletAllocation\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "id": "0452bb33",
   "metadata": {},
   "outputs": [],
   "source": [
    "#Loading data from csv\n",
    "data = pd.read_csv(\"data_19_rows.csv\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "id": "34e92788",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Index(['Unnamed: 0', 'Date of document', 'Title', 'Subtitle', 'CELEX number',\n",
       "       'EUROVOC descriptor', 'Subject matter', 'Directory code', 'Author',\n",
       "       'In force indicator', 'Content'],\n",
       "      dtype='object')"
      ]
     },
     "execution_count": 5,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "data.columns"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "id": "8f821ebf",
   "metadata": {},
   "outputs": [],
   "source": [
    "df_content = data.Content"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 18,
   "id": "60de17e6",
   "metadata": {},
   "outputs": [],
   "source": [
    "# Prepared function to later integrate notebook into .py files \n",
    "# def get_content(data):\n",
    "#     return data.content"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "id": "73fbc2b6",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "0     (1) Pursuant to Articles 9 and 168 of the Tre...\n",
       "1     (1) The objective of the Union’s policy on as...\n",
       "2     (1) The development of health technologies is...\n",
       "3     (1) The Commission communication of 29 Novemb...\n",
       "4     (1) The Commission communication of 29 Novemb...\n",
       "Name: Content, dtype: object"
      ]
     },
     "execution_count": 7,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_content.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "id": "a56f89aa",
   "metadata": {},
   "outputs": [],
   "source": [
    "# list used to remove unrelevant terms \n",
    "ignore_list = {'ec', 'no', 'european', 'commission', 'eu', 'union',\n",
    "                   'article', 'directive', 'council', 'regulation', 'official',\n",
    "                   'journal', 'article', 'information', 'agency', 'regulation',\n",
    "                   'mssg', 'data', 'member', 'states', 'etf', 'mdssg', 'shall'\n",
    "                  }"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "id": "b80f77c5",
   "metadata": {},
   "outputs": [],
   "source": [
    "def cleaning(sentence):\n",
    "    \n",
    "    # Basic cleaning\n",
    "    sentence = sentence.strip() ## remove whitespaces\n",
    "    sentence = sentence.lower() ## lowercasing \n",
    "    sentence = ''.join(char for char in sentence if not char.isdigit()) ## removing numbers\n",
    "    \n",
    "    # Advanced cleaning\n",
    "    for punctuation in string.punctuation:\n",
    "        sentence = sentence.replace(punctuation, '') ## removing punctuation\n",
    "    tokenized_sentence = word_tokenize(sentence) ## tokenizing \n",
    "    stop_words = set(stopwords.words('english')) ## defining stopwords\n",
    "    tokenized_sentence_cleaned = [w for w in tokenized_sentence \n",
    "                                  if not w in stop_words] ## remove stopwords\n",
    "    \n",
    "    #tokenized_sentence_cleaned = [w for w in tokenized_sentence_cleaned if not w in ignore_list] COMMENTED IGNORE OUT!\n",
    "    \n",
    "    sentences = ' '.join(word for word in tokenized_sentence_cleaned)\n",
    "    \n",
    "    #spacy\n",
    "    nlp = spacy.load('en_core_web_sm', disable=[\"parser\"])\n",
    "\n",
    "    doc = nlp(sentences)\n",
    "    lemmatized = \" \".join([token.lemma_ for token in doc])\n",
    "    \n",
    "    return lemmatized"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 12,
   "id": "ecfe7b7d",
   "metadata": {},
   "outputs": [],
   "source": [
    "# Applying Davy's Function\n",
    "\n",
    "clean_txt = df_content.apply(cleaning)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 13,
   "id": "abc7b1fd",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "0     pursuant article treaty function european unio...\n",
       "1     objective union ' policy asylum develop establ...\n",
       "2     development health technology key driver econo...\n",
       "3     commission communication november entitle ' fu...\n",
       "4     commission communication november entitle ' fu...\n",
       "5     technical difficulty breed due complex genetic...\n",
       "6     agreement withdrawal united kingdom great brit...\n",
       "7     regulation eu european parliament council expi...\n",
       "8     december commission adopt communication entitl...\n",
       "9     directive ec european parliament council lay r...\n",
       "10    regulation ec european parliament council subs...\n",
       "11    context evolve migratory challenge characteris...\n",
       "12    union ' objective ensure high level security w...\n",
       "13    national security remain solely competence mem...\n",
       "14    order achieve smart sustainable inclusive grow...\n",
       "15    european maritime fishery aquaculture fund ' e...\n",
       "16    existential threat pose climate change require...\n",
       "17    customs office situate external border union n...\n",
       "18    article treaty function european union tfeu pr...\n",
       "19    article treaty function european union tfeu pr...\n",
       "Name: Content, dtype: object"
      ]
     },
     "execution_count": 13,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "#Checking outcome of Preprocessing\n",
    "clean_txt\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 14,
   "id": "3a5d8adb",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "\"pursuant article treaty function european union ' tfeu ' article charter fundamental right european union ' charter ' union ensure high level human health protection definition implementation union policy activity covid pandemic highlighted interconnectedness human animal ecosystem health risk pose loss biodiversity earth recognise world health organization many microbe infect animal human effort focus human health animal health prevent eliminate problem disease transmission disease may transmit human animal vice versa therefore need tackle human animal take advantage potential synergy research treatment approximately emerge disease almost know pandemic namely influenza hivaid covid zoonoses disease increase globally past year change land use deforestation urbanisation agricultural expansion intensification wildlife traffic consumption pattern factor contribute increase zoonotic pathogen bacterial viral parasitic include unconventional agent able spread human direct contact food water environment covid pandemic clear example need reinforce application one health approach union achieve well public health outcome since state regulation eu european parliament council ' human health connect animal health environment … action tackle threat health must take account three dimension ' unprecedented experience covid pandemic also highlight difficulty union member state address public health emergency regard demonstrate need strengthen union ' role order effective manage availability medicinal product availability medical device vitro diagnostic medical device respective accessory collectively ' medical device ' develop medical countermeasure address threat pose public health early stage harmonise way ensure cooperation coordination union national regional competent authority medicinal product medical device industry actor supply chain medicinal product medical device include healthcare professional union need give high priority health ability ensure continue provision high quality healthcare service prepare address pandemics health threat severely impede absence clearly define legal framework manage response pandemics limit mandate resource health agency well limited degree union member states preparedness public health emergency impact majority member state shortage medicinal product medical device different complex root cause need map understand analyse together different stakeholder order comprehensively address well understanding shortage include identification vulnerability supply chain specific case covid pandemic shortage treatment disease variety cause range production difficulty third country logistical production difficulty within union shortage vaccine due inadequate manufacturing capacity disruption often complex supply chain medicinal product medical device national export restriction ban border closure impede free movement good uncertainty relate supply demand good context covid pandemic lack production union certain medicinal product active substance lead significant impediment smooth function internal market address serious threat public health across union serious consequence union ' citizen address issue shortage medicinal product longstande priority member states european parliament illustrate several report european parliament european parliament resolution september shortage medicine – address emerge problem well discussion within council european union however issue remain date unaddresse shortage medicinal product represent grow threat public health serious impact healthcare system right patient access appropriate medical treatment increase global demand medicinal product exacerbate covid pandemic lead shortage medicinal product weaken healthcare system member state pose significant risk patient ' health care patient particularly term disease progression worsen symptom long delay interruption care therapy long period hospitalisation increase risk exposure falsify medicinal product medication error adverse effect result substitution unavailable medicinal product alternative one significant psychological distress patient increase cost healthcare system covid pandemic exacerbated problem shortage certain medicinal product consider critical address pandemic highlight union ' external dependence term domestic production medicinal product medical device lack coordination structural limitation union ' member state ' ability rapidly effectively react challenge public health emergency also highlight need support strengthen industrial capacity produce medicinal product medical device appropriate policy well need active extensive involvement union institution body office agency protect health union citizen rapid evolution covid spread virus lead sharp increase demand medical device ventilator surgical mask covid test kit disruption production limit capacity rapidly increase production complexity global nature supply chain medical device lead severe supply difficulty certain time serious shortage medical device also lead member state compete respond legitimate need citizen thereby contribute uncoordinated action national level national hoarding stockpiling issue result new entity involve expedite production medical device subsequently result delay conformity assessment prevalence medical device overprice noncompliant unsafe case counterfeit therefore appropriate matter urgency longterm structure establish within european medicines agency ' agency ' establish regulation ec european parliament council ensure solid effective monitoring shortage medical device occur public health emergency coordination management shortage well increase early dialogue medical device industry healthcare professional prevent mitigate shortage covid pandemic subsequent public health emergency reveal need coordinate union approach crisis management although lack impact assessment accompany commission proposal regulation due emergencylike nature situation sufficient allocation resource term staff funding secure take account specificity health sector different member state uncertainty supply demand risk shortage medicinal product medical device public health emergency like covid pandemic trigger export restriction among member states national protective measure seriously impact function internal market thereby exacerbate consequence public health well lead need temporary export transparency export authorisation mechanism furthermore shortage medicinal product result serious risk health patient union due lack availability result medication error increase duration hospital stay adverse reaction increase risk fatality cause administration unsuitable medicinal product use substitute unavailable medicinal product respect medical device shortage lead lack diagnostic resource negative consequence public health measure disease deteriorate treat may also prevent health professional adequately carry task protect evidence covid pandemic serious consequence health shortage example insufficient supply covid test kit also significant impact control spread give pathogen therefore important appropriate framework union level coordinate union response shortage medicinal product medical device reinforce formalise monitor critical medicinal product medical device efficient way way avoid create unnecessary burden stakeholder place strain resource cause additional delay safe efficacious medicinal product treat prevent diagnose disease cause public health emergency identify develop notably joint effort public authority private sector academia make available union citizen soon possible emergency covid pandemic also highlight need coordinate assessment conclusion multinational clinical trial line do voluntary basis clinical trial expert member state prior date application regulation eu european parliament council need unionlevel advice use medicinal product national compassionate use programme use medicinal product indication cover marketing authorisation union order avoid delay implementation result research development availability new repurpose medicinal product covid pandemic ad hoc solution contingent arrangements commission agency marketing authorisation holder manufacturer actor supply chain medicinal product one side member state find order make available safe efficacious medicinal product treat covid prevent spread order facilitate speed development marketing authorisation treatment vaccine order ensure well function internal market safe efficacious medicinal product treatment covid prevention spread contribute high level human health protection therefore appropriate approximate strengthen rule monitor shortage medicinal product medical device facilitate research development medicinal product potential treat prevent diagnose disease cause public health emergency view strategically complement effort commission include health emergency preparedness response authority ' hera ' establish commission decision september union agency end order support assessment crisispreparedness crisismanagement framework provide regulation regard shortage medicinal product medical device commission able use outcome target stress test perform commission agency member state relevant actor stress test entail simulation public health emergency major event segment process procedure lay regulation test regulation aim ensure high level protection human health ensure smooth function internal market regard medicinal product medical device moreover regulation aim ensure quality safety efficacy medicinal product potential address public health emergency objective pursue simultaneously inseparably link without one secondary regard article tfeu regulation establish framework monitor reporting shortage medicinal product medical device public health emergency major event regard article point c tfeu regulation provide strengthen union framework ensure quality safety medicinal product medical device regulation establish framework address issue shortage medicinal product medical device public health emergency major event however shortage persistent problem increasingly affect health live union citizen decade therefore regulation first step towards improve union response persistent problem commission subsequently assess expansion framework ensure issue shortage medicinal product medical device address order improve crisis preparedness management respect medicinal product medical device increase resilience solidarity across union procedure respective role obligation different entity concern clarify framework establish regulation build ad hoc solution identify date response covid pandemic prove effective build experience good practice example third country remain flexible enough tackle future public health emergency major event efficient way benefit public health patient harmonise system monitoring shortage medicinal product medical device establish would facilitate appropriate access critical medicinal product medical device public health emergency major event serious impact public health system complement improved structure ensure appropriate management public health emergency major event coordinate provide advice research development relate medicinal product potential mitigate public health emergency major event order facilitate monitoring report actual potential shortage medicinal product medical device agency able request obtain information datum marketing authorisation holder concern manufacturer member state designate single point contact avoid duplication information request submit interfere obligation marketing authorisation holder article directive ec european parliament council notify member state product cease place market member state obligation article directive marketing authorisation holder wholesale distributor ensure appropriate continue supply medicinal product person legal entity authorise entitle supply medicinal product need patient member state question meet order facilitate prevention monitoring reporting shortage medicinal product agency set information technology platform know european shortage monitor platform ' esmp ' capable processing information supply demand critical medicinal product public health emergency major event outside situation allow reporting shortage medicinal product likely lead public health emergency major event facilitate development esmp exist system leverage use possible esmp allow national competent authority submit monitor information unmet demand include information receive marketing authorisation holder wholesale distributor person legal entity authorise entitle supply medicinal product public order anticipate shortage medicinal product esmp could also process additional information receive marketing authorisation holder wholesale distributor person legal entity authorise entitle supply medicinal product public order avert public health emergency major event esmp fully implement act sole portal marketing authorisation holder provide information require public health emergency major event view increase efficiency predictability public health emergency major event accelerate decisionmake process avoid duplication effort unjustified burden stakeholder order facilitate coordination role agency interoperability datum exist member state ’ platform monitor shortage system appropriate essential allow share relevant information esmp manage agency event actual future demand unknown due public health emergency major event important make pragmatic prediction demand certain medicinal product basis good available information context information datum available stock plan minimum stock collect member state agency take account identify demand far possible information datum essential make correct adjustment manufacture medicinal product avoid least mitigate impact shortage medicinal product however data stock available provide due national security interest member state provide agency estimate data volume demand respect medicinal product executive steering group establish within agency ensure robust response major event coordinate urgent action within union relation management issue relate supply medicinal product ' medicine shortage steering group – mssg ' mssg establish list critical medicinal product ensure monitoring product able provide advice recommendation necessary action take safeguard quality safety efficacy medicinal product well safeguard supply medicinal product ensure high level human health protection facilitate appropriate communication patient consumer one hand mssg member state could collect datum impact shortage medicinal product patient consumer share relevant information mssg order inform approach management shortage medicinal product order ensure inclusivity transparency work mssg appropriate engagement mssg relevant third party include representative medicinal product interest group market authorisation holder wholesale distributor appropriate actor supply chain medicinal product representative healthcare professional patient consumer mssg benefit agency ' extensive scientific expertise regard evaluation supervision medicinal product develop agency ' lead role coordinate support response shortage medicinal product covid pandemic order ensure high quality safe efficacious medicinal product potential address public health emergency develop make available within union soon possible public health emergency emergency task force establish within agency provide advice medicinal product ' emergency task force – etf ' etf provide advice scientific question relate development treatment vaccine clinical trial protocol free charge entity involve development marketing authorisation holder clinical trial sponsor public health body academia irrespective role development medicinal product decision clinical trial application remain within competence member states accordance regulation eu work etf separate work scientific committee agency carry without prejudice scientific assessment committee etf provide advice recommendation regard use medicinal product fight overcome publichealth emergencies committee medicinal product human use ' chmp ' established article regulation ec able use recommendation prepare scientific opinion compassionate early use medicinal product prior marketing authorisation mssg could also draw work etf develop critical medicine list establishment etfshould build support provide agency covid pandemic particular regard scientific advice clinical trial design product development well ' roll ' review emerge evidence ie ongoing basis allow efficient assessment medicinal product include vaccine public health emergency guarantee high level human health protection order ensure well function internal market medicinal product contribute high level humanhealth protection appropriate etf coordinate provide advice developer involve research development medicinal product potential treat prevent diagnose disease cause public health emergency etf provide advice clinical trial protocol developer clinical trial conduct union provide guidance clinically relevant endpoint target vaccine treatment order facilitate clinical trial design meeting criterion effective public health intervention experience clinical trial covid pandemic reveal tremendous amount duplication investigation intervention high number small trial underrepresentation important population subgroup base gender age ethnicity medical comorbiditie lack collaboration lead risk research waste international regulator point need improve clinical research agenda order generate robust evidence quality safety efficacy medicinal product main way obtain reliable evidence coordinate welldesigne adequately power large randomised control trial clinical trial result clinical datum produce relevant marketing authorisation grant make publicly available timely manner publication trial protocol start clinical trial would allow public scrutiny whenever necessary consider medicinal product human use may impact veterinary sector close liaison national competent authority veterinary medicinal product envisage although individual research entity may agree another party act sponsor order prepare single harmonise unionwide clinical trial protocol experience covid pandemic show initiative set large multinational trial struggle materialise due lack single entity able take responsibility activity sponsor within union well interact multiple member state address problem new unionwide unionfunded vaccine trial network call vaccelerate launch follow commission communication february entitle ' hera incubator anticipate together threat covid variant ' agency identify facilitate initiative give advice possibility act sponsor applicable allocate respective responsibility cosponsor accordance article regulation eu coordinate development clinical trial protocol approach would strengthen research environment union would promote harmonisation would avoid subsequent delay availability result research marketing authorisation file union sponsor could benefit union research funding available time public health emergency well exist clinical trial network facilitate development application submission run trial may particularly valuable trial establish union international public health research organisation agency publish european public assessment report epar medicinal product authorise accordance regulation ec provide information assessment medicinal product describe datum assess reason recommend whether medicinal product authorise epar include detailed information regard relevant presubmission activity regulation include name coordinator expert involve medicinal product developer request scientific advice presubmission phase overview scientific topic discuss view advice respect medical device executive steering group shortage medical device establish coordinate urgent action within union relation management supply demand issue medical device establish list critical medical device case public health emergency ' medical device shortage steering group – mdssg ' ensure coordination mdssg also liaise medical device coordination group ' mdcg ' established article regulation eu european parliament council appropriate respect member state able appoint representative mdssg mdcg operational phase work mssg mdssg etf trigger recognition public health emergency accordance decision eu european parliament council regard mssg also recognition major event continuous monitoring risk public health major event include manufacture issue natural disaster bioterrorism potential affect quality safety efficacy supply medicinal product also ensure addition monitor follow one health approach understand recommendation advice guidance opinion provide regulation inherently nonbinde instrument intend allow commission agency mssg mdssg etf make view know suggest line action without impose legal obligation addressee instrument imperative place robust transparency measure standard regard agency ' regulatory activity relation medicinal product medical device fall scope regulation measure include timely publication relevant information approve medicinal product medical device clinical datum include clinical trial protocol agency highly transparent regard membership recommendation opinion decision mssg mdssg etf member mssg mdssg etf financial interest medicinal product medical device industry could affect impartiality order establish list category critical medical device facilitate process monitoring shortage manufacturer medical device authorise representative necessary relevant notify body provide information request agency specific situation namely member state consider need provide temporary exemption pursuant article regulation eu article regulation eu european parliament council view mitigate actual potential shortage medical device importer distributor also play role provide request information noneu manufacturer designate authorise representative regulation provide agency role support expert panel medical device designate accordance article regulation eu ' expert panel ' provide independent scientific technical assistance member states commission mdcg notify body manufacturer uphold maximum transparency condition foster trust confidence union regulatory system addition role clinical evaluation assessment performance evaluation regard certain high risk medical device accordance regulations eu eu respectively well provide opinion response consultation manufacturer notify body expert panel provide scientific technical clinical assistance member states commission mdcg particular expert panel contribute development guidance number point include clinical performance aspect specific medical device category group medical device specific hazard relate category group medical device develop clinical evaluation performance evaluation guidance line state art contribute identification concern emerge issue safety performance context expert panel could play relevant role preparedness management public health emergency relate medical device particularly high risk include medical device potential address public health emergency without prejudice task obligation regulation eu eu give agency ' longstanding prove record expertise field medicinal product consider agency ' experience work multitude group expert appropriate establish suitable structure within agency monitor potential shortage medical device context public health emergency provide agency provide secretariat expert panel would ensure expert panel operate sustainably long term would provide clear synergy relate crisispreparedness work area medicinal product structure would way change regulatory system decisionmake procedure area medical device already place union remain clearly distinct medicinal product ensure smooth transition agency commission provide support expert panel march order facilitate work exchange information regulation provision make establishment management infrastructure create synergy exist system system development include european database medical device eudame provide article regulation eu alongside enhance protection datum infrastructure deterrence possible cyber attack within eudamed european medical device nomenclature provide article regulation eu article regulation eu use help gather relevant information categorisation medical device work could also facilitate appropriate emerge digital technology computational model simulation clinical trial well datum union space programme establish regulation eu european parliament council galileo geolocation service copernicus earth observation datum order ensure completeness information datum obtain agency consider specific characteristic medical device sector eudame fully functional possible constitute list single point contact monitoring shortage medical device include public health emergency critical device list use source information relevant database medical device association union national level rapid access exchange health datum include real world datum ie health datum generate outside clinical study essential ensure effective management public health emergency major event regulation allow agency use facilitate exchange part establishment operation european health data space interoperable infrastructure take advantage potential supercompute artificial intelligence big datum science develop predict model take well timely effective decision without compromise privacy right order facilitate reliable exchange information medicinal product robust consistent manner identification medicinal product base standard develop international organization standardization identification medicinal product human use handle sensitive datum crucial deal potential public health emergency require high level protection cyber attack healthcare organisation also face heighten cybersecurity threat midst covid pandemic agency target cyber attack result document relate covid medicinal product vaccine belong third party illegally access document leak internet therefore necessary agency equip high level security control process cyber attack ensure agency operate normally time especially public health emergency major event end agency establish plan prevent detect mitigate respond cyber attack operation secure time prevent illegal access documentation hold agency due sensitive nature health data agency safeguard processing operation ensure respect datum protection principle lawfulness fairness transparency purpose limitation datum minimisation accuracy storage limitation integrity confidentiality process personal datum necessary purpose regulation processing do accordance union law protection personal datum process personal datum regulation take place accordance regulations eu eu european parliament council credibility agency public trust decision depend high degree transparency therefore use adequate communication tool proactively engage general public provide addition rapid strengthen transparency standard measure regard agency ' work body clinical datum assess evaluation surveillance medicinal product medical device paramount gain uphold public trust regulation establish framework strengthen transparency standard measure basis transparency standard measure adopt agency covid pandemic public health emergency major event agency ensure cooperation european centre disease prevention control ' ecdc ' establish regulation ec european parliament council union agency appropriate cooperation include share datum include datum epidemiological forecasting regular communication executive level invite representative ecdc union agency attend meeting etf mssg mdssg appropriate cooperation also include strategic discussion relevant entity union position assist research development regard appropriate solution technology mitigate effect public health emergency major event prevent future similar public health emergency major event case public health emergency relation major event possible agency enable regular exchange information member state marketing authorisation holder relevant actor supply chain medicinal product representative healthcare professional patient consumer ensure early discussion potential shortage medicinal product market supply constraint allow well coordination synergy mitigate respond public health emergency major event give covid pandemic come end duration evolution public health emergency pandemics uncertain provision make review effectiveness function structure mechanism establish accordance regulation light review structure mechanism adjust appropriate since objective regulation sufficiently achieve member state alone due crossborder dimension public health emergency major event rather reason scale effect action well achieve union level union may adopt measure accordance principle subsidiarity set article treaty european union accordance principle proportionality set article regulation go beyond necessary order achieve objective order ensure sufficient resource include appropriate staffing adequate expertise available carry task provide regulation expenditure agency cover contribution union agency ' revenue expenditure include remuneration rapporteur appoint provide scientific service relation etf line usual practice reimbursement travel accommodation subsistence expense relate meeting mssg mdssg etf working party euhealth programme establish regulation eu recovery resilience facility establish regulation eu european parliament council tool provide additional support national competent authority relation shortage medicinal product include implementation action mitigate shortage medicinal product improve security supply member state able request financial support union specifically implementation obligation set regulation european data protection supervisor consult accordance article regulation eu deliver formal comment march accordance article tfeu regulation fully respect responsibility member state definition health policy organisation delivery health service medical care well fundamental right principle recognise charter include protection personal datum one aim regulation ensure strengthen framework monitor reporting shortage medicinal product public health emergency major event announce communication commission november entitle ' pharmaceutical strategy europe ' commission propose revise pharmaceutical legislation enhance security supply address shortage medicinal product specific measure legislation could cover coordinate role agency monitor manage shortage medicinal product result revision strengthen measure regard monitor reporting supply demand medicinal product union level require esmp consider suitable system facilitate new provision relate monitor reporting shortage medicinal product part reporting regulation commission consider need extend scope regulation include veterinary medicinal product personal protective equipment amend definition introduce measure union national level strengthen compliance obligation set regulation review include consideration remit function esmp extension function esmp need national shortage monitor system consider necessary order prepare shortage medicinal product public health emergency major event support monitoring shortage capacity building support union funding mechanism consider order enhance cooperation among member state could include exploration good practice coordination development tool monitor manage shortage medicinal product member state connect esmp ensure esmp use full potential identify forecast problem relate supply demand medicinal product appropriate esmp facilitate use big data technique artificial intelligence order allow prompt application measure provide regulation enter force day follow publication official journal european union adopt regulation within european medicines agency ' agency ' regulation provide framework mean prepare prevent coordinate manage impact public health emergency medicinal product medical device impact major event medicinal product medical device union level b monitoring prevent reporting shortage medicinal product shortage medical device c set interoperable information technology platform union level monitor report shortage medicinal product provide advice medicinal product potential address public health emergency e provide support expert panel provide article regulation eu purpose regulation follow definition apply ' public health emergency ' mean situation public health emergency recognise commission accordance article decision eu b ' major event ' mean event likely pose serious risk public health relation medicinal product one member state concern deadly threat otherwise serious threat health biological chemical environmental origin serious incident affect supply demand medicinal product quality safety efficacy medicinal product may lead shortage medicinal product one member state necessitate urgent coordination union level order ensure high level human health protection c ' medicinal product ' mean medicinal product define article point directive ec ' veterinary medicinal product ' mean veterinary medicinal product define article point regulation eu european parliament council e ' medical device ' mean medical device define article point regulation eu vitro diagnostic medical device define article point regulation eu include accessory device within mean article point regulation eu article point regulation eu respectively f ' supply ' mean total volume stock give medicinal product medical device place market marketing authorisation holder manufacturer g ' demand ' mean request medicinal product medical device healthcare professional patient response clinical need demand satisfactorily meet medicinal product medical device acquire appropriate time sufficient quantity allow continuity good care patient h ' shortage ' mean situation supply medicinal product authorise place market member state cemarke medical device meet demand medicinal product medical device national level whatever cause ' developer ' mean legal natural person seek generate scientific datum regard quality safety efficacy medicinal product part development product executive steering group shortage safety medicinal product ' medicine shortage steering group – mssg ' hereby establish within agency mssg shall responsible fulfilling task refer article article mssg shall meet regularly also whenever situation require either person remotely preparation public health emergency issue concern raise mssg commission recognise major event accordance article agency shall provide secretariat mssg member mssg shall consist representative agency representative commission one representative appoint member state member mssg may accompany meeting mssg expert specific scientific technical field list member mssg shall publish agency ' web portal representative agency ' patient ' consumer ’ work party ' pcwp ' representative agency ' healthcare professional ’ working party ' hcpwp ' may attend meeting mssg observer mssg shall cochaire representative agency one representative member state shall elect among representative member state mssg cochairs mssg initiative request one member mssg may invite observer provide expert advice representative national competent authority veterinary medicinal product representative relevant competent authority third party include representative medicinal product interest group market authorisation holder wholesale distributor appropriate actor supply chain medicinal product representative healthcare professional patient consumer attend meeting necessary mssg coordination national competent authority medicinal product shall facilitate appropriate communication marketing authorisation holder representative manufacturer relevant actor supply chain medicinal product representative healthcare professional patient consumer view receive relevant information actual potential shortage medicinal product consider critical public health emergency major event provide article mssg shall establish rule procedure include procedure relate working party refer paragraph article procedure adoption critical medicine list set information recommendation refer article rule procedure refer first subparagraph shall enter force mssg receive favourable opinion commission management board agency mssg shall support work working party establish accordance article point working party refer first subparagraph shall consist representative national competent authority medicinal product shall single point contact relation shortage medicinal product mssg may consult committee medicinal product veterinary use ' cvmp ' establish article point b regulation ec whenever mssg deem necessary particular order deal public health emergency major event relate zoonoses disease affect animal may major impact human health use active substance veterinary medicinal product may useful address public health emergency major event agency collaboration member state shall continuously monitor event likely lead public health emergency major event necessary agency shall cooperate european centre disease prevention control ' ecdc ' relevant union agency facilitate monitor refer paragraph national competent authority medicinal product act single point contact refer article platform refer article ' esmp ' fully functional shall report timely manner agency event likely lead public health emergency major event include actual potential shortage medicinal product give member state reporting shall base reporting method criterion pursuant article point b national competent authority inform agency shortage medicinal product refer first subparagraph shall provide agency information receive marketing authorisation holder pursuant article directive ec information available esmp agency receive report event national competent authority medicinal product agency may request information national competent authority work party refer article order evaluate impact event member states agency consider actual imminent major event need address shall raise issue concern mssg follow positive opinion mssg commission may recognise major event commission least one member state may raise issue concern mssg initiative mssg shall inform commission executive director agency mssg consider major event sufficiently address consider assistance long need basis information refer first subparagraph initiative commission executive director may confirm major event sufficiently address therefore assistance mssg long need follow recognition public health emergency recognition major event accordance paragraph article article apply follow public health emergency major event may affect quality safety efficacy medicinal product article apply b public health emergency major event may lead shortage medicinal product one member state article apply follow recognition public health emergency recognition major event accordance article mssg shall evaluate information relate public health emergency major event consider need urgent coordinate action regard quality safety efficacy medicinal product concern mssg shall provide recommendation commission member state appropriate action believe need take union level medicinal product concern accordance directive ec regulation ec mssg may consult cvmp whenever mssg deem necessary particular order deal public health emergency major event relate zoonoses disease affect animal may major impact human health use active substance veterinary medicinal product may useful address public health emergency major event without prejudice paragraph mssg shall establish list main therapeutic group medicinal product necessary emergency care surgery intensive care order inform preparation critical medicine list refer paragraph use respond public health emergency major event list shall establish august update annually whenever necessary immediately follow recognition major event accordance article regulation mssg shall consult work party refer article regulation immediately follow consultation mssg shall adopt list medicinal product authorise accordance directive ec regulation ec consider critical major event ' major event critical medicine list ' mssg shall update major event critical medicine list whenever necessary major event sufficiently address confirm assistance mssg long need pursuant article regulation immediately follow recognition public health emergency mssg shall consult work party refer article regulation immediately follow consultation mssg shall adopt list medicinal product authorise accordance directive ec regulation ec consider critical public health emergency ' public health emergency critical medicine list ' mssg shall update public health emergency critical medicine list whenever necessary termination recognition public health emergency public health emergency critical medicine list may update take account result review process article regulation appropriate case mssg shall liaise emergency task force refer article regulation ' etf ' purpose article mssg shall adopt make publicly available set information refer article point c necessary monitor supply demand medicinal product include list refer paragraph article ' critical medicine list ' shall inform work party refer article set information follow adoption critical medicine list accordance paragraphs agency shall immediately publish list update list web portal refer article regulation ec agency shall establish within web portal publicly accessible webpage provide information actual shortage medicinal product include critical medicine list case agency assess shortage provide recommendation healthcare professional patient webpage shall provide least follow information name common name medicinal product critical medicine list b therapeutic indication medicinal product critical medicine list c reason shortage medicinal product critical medicine list start end date shortage medicinal product critical medicine list e member state affect shortage medicinal product critical medicine list f relevant information healthcare professional patient include information whether alternative medicinal product available webpage refer first subparagraph shall also provide reference national registry shortage medicinal product follow recognition public health emergency recognition major event accordance article mssg shall monitor supply demand medicinal product include critical medicine list view identify actual potential shortage medicinal product mssg shall conduct monitoring use critical medicine list information datum provide accordance article available esmp fully functional purpose monitor refer first paragraph article relevant mssg shall liaise health security committee establish article decision eu ' hsc ' case public health emergency relevant advisory committee public health emergency establish pursuant union law ecdc duration public health emergency follow recognition major event refer article confirm major event sufficiently address pursuant article mssg shall regularly report result monitor refer article commission single point contact refer article particular shall signal actual potential shortage medicinal product include critical medicine list event likely lead major event report refer first subparagraph may also make available actor supply chain medicinal product appropriate accordance competition law request commission one single point contact refer article mssg shall provide aggregated datum demand forecast support finding conclusion regard mssg shall use datum esmp fully functional b liaise ecdc obtain epidemiological data model development scenario help forecast medicinal product need c liaise executive steering group shortage medical device refer article ' mdssg ' medicinal product include critical medicine list use jointly medical device aggregate datum demand forecast refer first subparagraph may also make available actor supply chain medicinal product appropriate accordance competition law view well prevent mitigate actual potential shortage medicinal product part report refer paragraph mssg may provide recommendation measure commission member state marketing authorisation holder entity include representative healthcare professional patient could take prevent mitigate actual potential shortage medicinal product member state may request mssg provide recommendation measure refer first subparagraph purpose second subparagraph mssg shall liaise relevant hsc case public health emergency relevant advisory committee public health emergency establish pursuant union law mssg initiative request commission member state may provide recommendation measure commission member state marketing authorisation holder representative healthcare professional entity could take ensure preparedness deal actual potential shortage medicinal product cause public health emergency major event request commission mssg may coordinate measure take national competent authority marketing authorisation holder entity include representative healthcare professional patient relevant prevent mitigate actual potential shortage medicinal product context public health emergency major event order prepare fulfilment task refer article agency shall specify procedure criterion establish review critical medicine list b specify method criterion monitor data collection reporting provide article basic minimum datum set c develop streamline monitor reporting system coordination relevant national competent authority facilitate interoperability exist system system development esmp fully functional basis data field harmonise across member state establish working party refer article ensure member state represent work party e establish maintain list single point contact marketing authorisation holder medicinal product authorise union database provide article point l regulation ec f specify method provision recommendation refer article article coordination measure refer article g publish information cover point b f dedicated webpage web portal purpose first subparagraph point member state marketing authorisation holder relevant actor supply chain medicinal product representative healthcare professional patient consumer may consult necessary follow recognition public health emergency recognition major event accordance article agency shall establish list single point contact marketing authorisation holder medicinal product include critical medicine list b maintain list single point contact refer point duration public health emergency major event c request relevant information medicinal product critical medicine list single point contact refer point set deadline submission information information available esmp request information medicinal product critical medicine list single point contact refer article basis set information refer article set deadline submission information information available esmp information refer paragraph point c shall include least name marketing authorisation holder medicinal product b name medicinal product c identification active manufacturing site finish product active substance medicinal product member state marketing authorisation valid marketing status medicinal product member state e details actual potential shortage medicinal product actual estimate start end date suspect know cause f sale market share datum medicinal product g available stock medicinal product h forecast supply medicinal product include information potential vulnerability supply chain quantity already deliver project delivery demand forecast medicinal product j detail available alternative medicinal product k shortage prevention mitigation plan include minimum information production supply capacity approve production site finish medicinal product active substance potential alternative production site minimum stock level medicinal product order supplement shortage prevention mitigation plan critical medicinal product refer paragraph point k agency national competent authority medicinal product may request information wholesale distributor relevant actor regard logistical challenge incur wholesale supply chain marketing authorisation holder medicinal product authorise union shall provide information purpose article point e regulation september form electronic submission database refer article point l regulation ec marketing authorisation holder shall provide update necessary order facilitate monitoring refer article agency may request marketing authorisation holder medicinal product include critical medicine list submit information refer article point c marketing authorisation holder refer first subparagraph paragraph shall submit request information deadline set agency single point contact refer article point b use monitor reporting method system establish pursuant article point b c respectively market authorisation holder shall provide update necessary marketing authorisation holder refer paragraph shall justify failure provide request information delay provide request information deadline set agency marketing authorisation holder refer paragraph indicate information submit request agency national competent authority medicinal product contain information commercially confidential nature shall identify relevant part information nature explain information commercially confidential nature agency shall assess merit indication information commercially confidential nature protect commercially confidential information unjustified disclosure marketing authorisation holder refer paragraph relevant actor supply chain medicinal product information addition require paragraph second subparagraph provide evidence actual potential shortage medicinal product shall immediately provide information agency follow report result monitor refer article recommendation preventive mitigating measure provide accordance article marketing authorisation holder refer paragraph shall provide comment agency b take account recommendation refer article guideline refer article point c c comply measure take union member state level pursuant article inform mssg measure take report monitoring result measure include provide information resolution actual potential shortage medicinal product order facilitate monitoring refer article unless information concern available esmp agency may request member state submit set information refer article include available estimate datum volume demand demand forecast single point contact refer article use reporting method system establish pursuant article point b c respectively b indicate existence commercially confidential information explain information commercially confidential nature accordance article c indicate failure provide request information whether delay provide information deadline set agency accordance article member state shall comply agency ' request deadline set agency purpose paragraph wholesale distributor person legal entity authorise entitle supply medicinal product include critical medicine list public shall provide member state relevant information datum include information data level stock medicinal product request member state member state information addition information provide accordance paragraph article volume sale volume prescription medicinal product provide evidence actual potential shortage medicinal product include critical medicine list include datum refer article third paragraph directive ec shall immediately provide information mssg respective single point contact refer article regulation follow report result monitor refer article recommendation preventive mitigating measure provide accordance article member state shall take account recommendation guideline refer article point c coordinate action relation action take union level pursuant article point b inform mssg measure take report result action refer point include provide information resolution actual potential shortage medicinal product purpose first subparagraph point b member state take alternative course action national level shall share reason mssg timely manner recommendation guideline action refer first subparagraph point summary report lesson learn shall make publicly available via web portal refer article commission shall take account information recommendation mssg refer article article respectively shall take necessary action within limit power confer commission view mitigate actual potential shortage medicinal product include critical medicine list b facilitate coordination marketing authorisation holder relevant entity address demand surge necessary c consider need guideline recommendation address member state marketing authorisation holder entity include relevant entity supply chain medicinal product relevant inform mssg measure take commission report result measure e request mssg provide recommendation coordinate measure provide article f consider need medical countermeasure accordance decision eu applicable union law g liaise third country relevant international organisation appropriate mitigate actual potential shortage medicinal product include critical medicine list active substance medicinal product active substance import union actual potential shortage international implication report related action well result action mssg relevant agency shall set maintain manage platform know european shortage monitor platform ' esmp ' shall link database refer article point l regulation ec esmp shall use facilitate collection information shortage supply demand medicinal product include information whether medicinal product place cease place market member state information collect esmp shall use monitor prevent manage actual potential shortage medicinal product critical medicine list public health emergency major event b actual potential shortage medicinal product likely lead public health emergency major event accordance article purpose paragraph public health emergenciesand major event marketing authorisation holder shall use esmp report information relate medicinal product critical medicine list agency single point contact refer article point accordance article b member state shall use esmp report information relate medicinal product critical medicine list agency single point contact refer article point accordance article report refer first subparagraph point b shall include information addition refer point receive marketing authorisation holder wholesale distributor person legal entity authorise entitle supply public medicinal product include critical medicine list relevant purpose paragraph regard ensure preparedness public health emergency major event marketing authorisation holder shall use esmp report agency information refer article regulation ec authorisation grant accordance regulation ii information base category set article relate actual potential shortage medicinal product likely lead public health emergency major event appropriate b member state shall use esmp report agency shortage medicinal product likely lead public health emergency major event accordance article single point contact refer article point e report refer paragraph point b shall include information refer article directive ec report national competent authority medicinal product authorisation grant accordance directive b may include additional information receive marketing authorisation holder wholesale distributor person legal entity authorise entitle supply medicinal product public ensure optimal use esmp agency shall develop technical functional specification esmp include datum exchange mechanism exchange exist national system format electronic submission collaboration mssg b require datum submit esmp comply standard develop international organization standardization identification medicinal product base domain master datum pharmaceutical regulatory process namely substance product organisation referential datum relevant c develop standardise reporting terminology use marketing authorisation holder member state report esmp collaboration mssg establish relevant guidance reporting esmp collaboration mssg e ensure data interoperable esmp member state ’ system relevant system database without duplication report f ensure commission agency national competent authority mssg appropriate level access information contain esmp g ensure commercially confidential information submit system protect unjustified disclosure h ensure esmp fully operational february draw plan implementation esmp agency shall provide information public interest group regard work mssg timely manner shall respond disinformation target work mssg appropriate via dedicated webpage web portal appropriate mean cooperation national competent authority proceeding mssg shall transparent summary agenda minute meeting mssg well rule procedure refer article recommendation refer article shall document make publicly available dedicated webpage agency web portal rule procedure refer article allow member mssg divergent opinion record mssg shall make divergent opinion ground base available national competent authority medicinal product request emergency task force ' etf ' hereby establish within agency etf shall convene preparation public health emergency either person remotely agency shall provide secretariat etf public health emergency etf shall undertake follow task liaison scientific committee work party scientific advisory group agency provide scientific advice review available scientific datum medicinal product potential address public health emergency include request data developer engage preliminary discussion b provide advice main aspect clinical trial protocol provide advice developer clinical trial medicinal product intend treat prevent diagnose disease cause public health emergency accordance article regulation without prejudice task member state regard assessment submit clinical trial application conduct within territory accordance regulation eu c provide scientific support facilitate clinical trial medicinal product intend treat prevent diagnose disease cause public health emergency contribute work scientific committee work party scientific advisory group agency e liaison scientific committee work party scientific advisory group agency provide scientific recommendation regard use medicinal product potential address public health emergency accordance article f cooperate national competent authority union body agency world health organization third country international scientific organisation scientific technical issue relate public health emergency medicinal product potential address public health emergency necessary support refer first subparagraph point c shall include advice sponsor similar link plan clinical trial establishment joint clinical trial may include advice establish agreement act sponsor cosponsor accordance article point article regulation eu member etf shall consist chair vice chair scientific committee agency representatives committees b representative work party agency include representative pcwp representative hcpwp c staff member agency representatives coordination group establish accordance article directive ec e representatives clinical trial coordination advisory group establish accordance article regulation eu f clinical trial expert represent national competent authority medicinal product member etf shall nominate entity represent external expert may appoint etf ad hoc basis necessary especially case refer article representative union body agency shall invite ad hoc basis necessary participate work etf especially case refer article etf shall chair representative agency cochaire chair vicechair chmp composition etf shall approve management board agency take account specific expertise relevant therapeutic response public health emergency executive director agency representative executive director well representatives commission management board agency shall entitle attend meeting etf composition etf shall make publicly available cochair etf may invite representative member states member scientific committee work party agency third party include representative medicinal product interest group market authorisation holder developer clinical trial sponsor representative clinical trial network independent clinical trial expert researcher representative healthcare professional patient attend meeting etf shall establish rule procedure include rule adoption recommendation rule procedure refer first subparagraph shall enter force etf receive favourable opinion commission management board agency etf shall perform task advisory support body separate without prejudice task scientific committee agency regard authorisation supervision pharmacovigilance medicinal product concern related regulatory action ensure quality safety efficacy medicinal product chmp relevant scientific committee agency shall take etf recommendation consideration adopt opinion etf shall take account scientific opinion issue committee refer second subparagraph paragraph accordance regulation ec directive ec article regulation ec apply etf regard transparency independence member agency shall publish information regard medicinal product etf consider potential address public health emergency update web portal agency shall inform member state hsc appropriate publication without undue delay case prior publication public health emergency etf shall provide advice main aspect clinical trial clinical trial protocol submit intend submit clinical trial application developer part accelerate scientific advice process without prejudice responsibility member state state concern regulation eu developer engage accelerate scientific advice process etf shall provide advice refer paragraph free charge late day developer submit complete set request information datum agency advice shall endorse chmp etf shall establish procedure guidance request submit set information datum require include information member state state application authorisation clinical trial submit intend submit etf shall involve representative member states clinical trial expertise preparation scientific advice particular case application authorisation clinical trial submit intend submit authorise clinical trial application etf provide scientific advice member state shall take advice consideration scientific advice provide etf shall without prejudice ethical review provide regulation eu developer recipient scientific advice refer paragraph article developer shall subsequently submit datum result clinical trial agency agency make request datum pursuant article without prejudice paragraph article scientific advice refer paragraph article shall otherwise provide accordance procedure establish pursuant article regulation ec duration public health emergency sponsor clinical trial conduct union shall particular make follow information publicly available eu portal eu database establish respectively article regulation eu clinical trial protocol start trial trial authorise regulation eu examine medicinal product potential address public health emergency b summary result within timeline set agency short timeline lay article regulation eu medicinal product relevance public health emergency receive marketing authorisation agency shall publish particular product information detail condition use time marketing authorisation b european public assessment report soon possible possible within seven day marketing authorisation c clinical datum submit agency support application possible within two month marketing authorisation commission entire risk management plan refer article point c directive ec update version thereof purpose first subparagraph point c agency shall anonymise personal datum redact commercially confidential information follow recognition public health emergency etf shall undertake review available scientific datum medicinal product potential use address public health emergency review shall update whenever need public health emergency include etf chmp agree preparation assessment marketing authorisation application preparation review refer paragraph etf may request information datum marketing authorisation holder developer may engage preliminary discussion etf may also make use health datum generate outside clinical study available take account reliability datum etf may liaise third country agency medicinal product respect additional information data exchange follow request one member states commission etf shall provide recommendation chmp opinion accordance paragraph compassionate use medicinal product fall scope directive ec regulation ec b use distribution unauthorised medicinal product accordance article directive ec follow receipt recommendation provide pursuant paragraph chmp shall adopt opinion condition impose use distribution medicinal product concern patient target opinion shall update necessary member state shall take account opinion refer paragraph article article directive ec apply use opinion preparation recommendation provide pursuant paragraph etf may consult member state concern request provide available information datum member state use decision make medicinal product available compassionate use follow request member state shall provide request information datum agency shall provide information public relevant interest group regard work etf timely manner shall respond disinformation target work etf appropriate via dedicated webpage web portal appropriate mean cooperation national competent authority agency shall regularly publish web portal list member etf rule procedure refer article list medicinal product review well opinion adopt pursuant article preparation support work etf public health emergency agency shall develop maintain tool include interoperable platform submission information datum include electronic health datum generate outside clinical study facilitate interoperability exist tool tool development provide adequate support national competent authority b coordinate independent monitoring study use effectiveness safety medicinal product intend treat prevent diagnose disease relate public health emergency use relevant datum include relevant datum hold public authority c part regulatory task make use digital infrastructure tool order facilitate rapid access analysis available electronic health datum generate outside clinical study facilitate exchange datum member states agency union body provide etf access external source electronic health datum agency access include health datum generate outside clinical study purpose first paragraph point b coordination regard vaccine shall conduct conjunction ecdc particular new vaccine monitor platform executive steering group shortage medical device ' medical device shortage steering group – mdssg ' hereby establish within agency mdssg shall responsible fulfilling task refer article mdssg shall meet regularly also whenever situation require either person remotely preparation public health emergency agency shall provide secretariat mdssg member mdssg shall consist representative agency representative commission one representative appoint member state representative member state shall expertise field medical device relevant representative may representative appoint medical device coordination group establish article regulation eu ' mdcg ' appropriate member mdssg may accompany meeting mdssg expert specific scientific technical field list member mdssg shall publish agency ' web portal representative pcwp representative hcpwp may attend meeting mdssg observer mdssg shall cochaire representative agency one representative member state shall elect among representative member state mdssg cochairs mdssg initiative request one member mdssg may invite observer provide expert advice third party include representative medical device interest group representative manufacturer notify body relevant actor supply chain medical device representative healthcare professional patient consumer attend meeting necessary mdssg shall establish rule procedure include procedure relate working party refer paragraph article procedure adoption list refer article set information recommendation refer article rule procedure refer first subparagraph shall enter force mdssg receive favourable opinion commission management board agency mdssg shall support work working party establish accordance article working party refer first subparagraph shall consist representative national competent authority responsible shortage monitor management medical device shall single point contact relation shortage medical device immediately follow recognition public health emergency mdssg shall consult work party refer article immediately follow consultation mdssg shall adopt list category critical medical device consider critical public health emergency ' public health emergency critical device list ' extent possible relevant information critical medical device relate manufacturer shall gather eudame fully functional information shall also gather importer distributor appropriate eudame fully functional available information may also gather national database available source mdssg shall update public health emergency critical device list whenever necessary termination recognition public health emergency purpose article mdssg shall adopt make publicly available set information refer article point b c necessary monitor supply demand medical device include public health emergency critical device list inform work party refer article set information agency shall publish dedicated webpage web portal public health emergency critical device list well update list b information actual shortage critical medical device include public health emergency critical device list public health emergency mdssg shall monitor supply demand medical device include public health emergency critical device list view identify actual potential shortage medical device mdssg shall conduct monitoring use public health emergency critical device list information datum provide accordance article purpose monitor refer first subparagraph paragraph relevant mdssg shall liaise mdcg hsc relevant advisory committee public health emergency establish pursuant union law purpose monitor refer paragraph article mdssg may make use datum device registrie database datum available agency mdssg may take account datum generate pursuant article regulation eu article regulation eu duration public health emergency mdssg shall regularly report result monitor refer article commission single point contact refer article point particular shall signal actual potential shortage medical device include public health emergency critical device list request commission member state one single point contact refer article point mdssg shall provide aggregated datum demand forecast support finding conclusion purpose first subparagraph mdssg shall liaise ecdc obtain epidemiological datum help forecast medical device need mssg medical device include public health emergency critical device list use jointly medicinal product finding conclusion mdssg refer first subparagraph may make available actor medical device sector appropriate accordance competition law view well prevent mitigate actual potential shortage part report refer paragraph mdssg may provide recommendation measure commission member states medical device manufacturer notify body entity could take prevent mitigate actual potential shortage medical device purpose first subparagraph mdssg shall liaise relevant mdcg hsc relevant advisory committee public health emergency establish pursuant union law mdssg initiative request commission may provide recommendation measure commission member states manufacturers medical device notify body entity could take ensure preparedness deal actual potential shortage medical device cause public health emergency request commission mdssg may coordinate measure take national competent authority medical device manufacturer medical device notify body entity relevant prevent mitigate actual potential shortage medical device context public health emergency major event order prepare fulfilment task refer article agency shall specify procedure criterion establish review public health emergency critical device list b develop streamline monitor reporting system coordination relevant national competent authority facilitate interoperability exist tool eudame fully functional provide adequate support national competent authority monitor report c establish working party refer article ensure member state represent work party specify method provision recommendation refer article coordination measure refer article purpose first subparagraph point mdcg representatives manufacturer relevant actor supply chain medical device sector representative healthcare professional patient consumer may consult necessary follow recognition public health emergency agency shall establish list single point contact manufacturer medical device authorise representative importer notify body medical device include public health emergency critical device list b maintain list single point contact refer point duration public health emergency c request relevant information medical device include public health emergency critical device list single point contact refer point basis set information adopt mdssg set deadline submission information request relevant information medical device include public health emergency critical device list single point contact refer article second subparagraph basis set information adopt mdssg accordance article set deadline submission information agency may use source refer first subparagraph include exist database database development gather information require paragraph purpose first subparagraph point consider relevant national union database include eudame fully functional medical device association may use source information information refer paragraph point c shall include least name manufacturer medical device applicable name authorise representative b information identify medical device intend purpose necessary specific characteristic medical device c applicable name number notify body information regard relevant certificate certificate detail actual potential shortage medical device actual estimate start end date suspect know cause e sale market share datum medical device f available stock medical device g forecast supply medical device include information potential vulnerability supply chain h quantity already deliver project delivery medical device demand forecast medical device j shortage prevention mitigation plan include minimum information production supply capacity k information relevant notify body regard capacity process application carry complete conformity assessment relation medical device include public health emergency critical device list within appropriate period time consider emergency l information number application receive relevant notify body relation medical device include public health emergency critical device list relevant conformity assessment procedure conformity assessment ongoing status conformity assessment relevant notify body relation medical device include public health emergency critical device list possible critical issue final outcome assessment need consider order complete conformity assessment process purpose first subparagraph point k relevant notify body shall communicate date assessment expect complete regard notify body shall prioritise conformity assessment medical device include public health emergency critical device list order facilitate monitoring refer article agency may request manufacturer medical device authorise representative applicable appropriate importer distributor include public health emergency critical device list necessary relevant notify body submit information request deadline set agency manufacturer medical device authorise representative applicable appropriate importer distributor refer first subparagraph shall submit request information single point contact refer article point use monitor reporting system establish pursuant article point b shall provide update necessary manufacturer medical device authorise representative applicable notify body appropriate importer distributor shall justify failure provide request information delay provide request information deadline set agency manufacturer medical device authorise representative notify body appropriate importer distributor indicate information submit contain information commercially confidential nature shall identify relevant part information nature explain information commercially confidential nature agency shall assess merit indication information commercially confidential nature protect commercially confidential information unjustified disclosure manufacturer medical device authorise representative notify body appropriate importer distributor information addition require paragraph provide evidence actual potential shortage medical device shall immediately provide information agency follow report result monitor refer article recommendation preventive mitigating measure provide accordance article manufacturer medical device authorise representative appropriate importer distributor refer paragraph shall provide comment agency b take account recommendation refer article guideline refer article point b c comply measure take union member state level pursuant article inform mdssg measure take report result measure include provide information resolution actual potential shortage medical device manufacturer medical device refer paragraph establish outside union information request accordance article shall provide authorise representative appropriate importer distributor order facilitate monitoring refer article agency may request member state submit set information refer article include available information need related medical device include public health emergency critical device list available estimate datum volume demand demand forecast medical device respective single point contact refer article point use monitor reporting method system establish pursuant article point b b indicate existence commercially confidential information explain information commercially confidential nature accordance article c indicate failure provide request information whether delay provide information deadline set agency accordance article member state shall comply agency ' request deadline set agency purpose paragraph member state shall gather information manufacturer medical device authorise representative healthcare provider importer distributor applicable notify body medical device include public health emergency critical device list member state information addition information provide accordance paragraph article provide evidence actual potential shortage medical device shall immediately provide information mdssg respective single point contact refer article point follow report result monitor refer article recommendation preventive mitigating measure provide accordance article member state shall consider need provide temporary exemption member state level pursuant article regulation eu article regulation eu view mitigate actual potential shortage medical device include public health emergency critical device list ensure high level patient product safety b take account recommendation refer article guideline refer article point b coordinate action relation action take union level pursuant article point c inform mdssg measure take report result action refer point b include provide information resolution actual potential shortage medical device concerned purpose first subparagraph point b c member state take alternative course action national level shall share reason mdssg recommendation guideline action refer first subparagraph point b paragraph summary report lesson learn shall make publicly available via web portal refer article commission shall take account information recommendation mdssg shall take necessary action within limit power confer commission view mitigate actual potential shortage medical device include public health emergency critical device list include necessary grant temporary exemption union level pursuant article regulation eu article regulation eu respect condition set article seek ensure patient product safety b consider need guideline recommendation address member state manufacturers medical device notify body entity relevant c request mdssg provide recommendation coordinate measure provide article consider need medical countermeasure accordance decision eu applicable union law e liaise third country relevant international organisation appropriate mitigate actual potential shortage medical device include public health emergency critical device list component part device part device import union actual potential shortage international implication report related action well result action mdssg relevant agency shall provide information public relevant interest group regard work mdssg timely manner shall respond disinformation target work mdssg appropriate via dedicated webpage web portal appropriate mean cooperation national competent authority proceeding mdssg shall transparent summary agenda minute meeting mdssg well rule procedure refer article recommendation refer article shall document make publicly available dedicated webpage agency web portal rule procedure refer article allow member mdssg divergent opinion record mdssg shall make divergent opinion ground base available national competent authority request march behalf commission agency shall provide secretariat expert panel designate accordance article regulation eu ' expert panel ' shall provide support necessary ensure expert panel efficiently perform task set article regulation agency shall provide administrative technical support expert panel provision scientific opinion view advice b facilitate manage remote physical meeting expert panel c ensure work expert panel carry independent manner accordance article second subparagraph article regulation eu system procedure establish commission pursuant regulation actively manage prevent potential conflict interest accordance article third subparagraph regulation maintain regularly update webpage expert panel make necessary information already publicly available eudame publicly available webpage order ensure transparency activity expert panel include provide justification notify body body follow advice expert panel provide pursuant article regulation eu e publish scientific opinion view advice expert panel ensure confidentiality accordance article second subparagraph article regulation eu f ensure remuneration expense provide expert accordance implement act adopt commission pursuant article regulation eu g monitor compliance expert panel ’ common rule procedure available guideline methodology relevant function expert panel h provide annual report commission mdcg work expert panel include information number opinion deliver view advice provide expert panel agency shall ensure mssg mdssg cooperate relation measure address public health emergency major event member mssg mdssg member work party refer article article point respectively may attend one another ' meeting work party appropriate cooperate monitoring exercise report preparation opinion agreement respective chair cochair joint meeting mssg mdssg may hold relevant agency shall ensure etf expert panel cooperate relation preparedness management public health emergency mssg mdssg shall carry activity independent impartial transparent manner member mssg mdssg relevant observer shall financial interest medicinal product industry medical device industry could affect independence impartiality member mssg mdssg relevant observer shall make declaration financial interest shall update declaration interest annually whenever necessary declaration refer first subparagraph shall make publicly available agency ' web portal member mssg mdssg relevant observer shall disclose fact become aware might reasonably expect good faith involve give rise conflict interest meeting member mssg mdssg relevant observer participate meeting mssg mdssg shall declare interest could consider prejudicial independence impartiality respect item agenda agency decide interest declare accordance paragraph constitute conflict interest member observer concern shall take part discussion decision make obtain information concern item concern agenda declaration decision agency refer paragraph respectively shall record summary minute meet member mssg mdssg relevant observer shall subject requirement professional secrecy even duty cease member etf shall update annual declaration financial interest provide article regulation ec whenever relevant change declaration occur agency shall equip high level security control process cyber attack cyber espionage datum breach ensure protection health data normal function agency time especially public health emergency major event union level purpose first paragraph agency shall actively identify implement cybersecurity good practice adopt within union institution body office agency prevent detect mitigating respond cyber attack unless otherwise provide regulation without prejudice regulation ec european parliament council directive eu european parliament council exist national provision practice member state confidentiality party involve application regulation shall respect confidentiality information datum obtain carry task order protect commercially confidential information trade secret natural legal person accordance directive eu european parliament council include intellectual property right without prejudice paragraph party involve application regulation shall ensure commercially confidential information share way potential enable undertaking restrict distort competition within mean article tfeu without prejudice paragraph information exchange confidential basis national competent authority national competent authorities commission agency shall disclose without prior agreement authority information originate paragraph affect rights obligations commission agency member states actor identify regulation regard exchange information dissemination warning affect obligation person concern provide information criminal law commission agency member state may exchange commercially confidential information regulatory authority third country conclude bilateral multilateral confidentiality arrangement transfer personal datum regulation shall subject regulation eu eu applicable regard transfer personal datum third country absence adequacy decision appropriate safeguard refer article regulation eu article regulation eu respectively commission agency member state may carry certain transfer personal datum regulatory authority third country put place confidentiality arrangement transfer necessary important reason public interest protection public health transfer shall make conformity condition lay article regulation eu article regulation eu december every fourth year thereafter commission shall present report european parliament council application regulation particular report shall review crisis preparedness management framework medicinal product medical device include outcome periodic stress test b instance noncompliance obligation set article market authorisation holder manufacturer medical device authorise representative importer distributor notify body c remit function esmp notwithstanding paragraph follow public health emergency major event commission shall present timely manner report european parliament council instance refer paragraph point b base report refer paragraph commission shall appropriate present legislative proposal order amend regulation particular commission shall consider need extend scope regulation veterinary medicinal product personal protective equipment medical use b amend article c introduce measure strengthen union national level compliance obligation establish article expand remit esmp need facilitate esmp interoperability national union system need national shortage monitoring platform need meet additional requirement address structural shortage medicinal product may introduce context revision directive ec regulation ec union shall provide financing agency ' activity support work mssg mdssg etf working party refer article article point c expert panel involve cooperation commission ecdc union ' financial assistance activity regulation shall implement accordance regulation eu euratom european parliament council agency shall remunerate assessment activity rapporteur relation etf regulation addition reimburse expense incur member state ’ representative expert relation meeting mssg mdssg etf working party refer article article accordance financial arrangement establish management board agency remuneration shall pay relevant national competent authority union contribution provide article regulation ec shall cover task agency provide regulation shall cover full amount remuneration pay national competent authority medicinal product fee exemption apply accordance council regulation ec regulation shall enter force day follow publication official journal european union shall apply march however exception article chapter iv shall apply february regulation shall bind entirety directly applicable member state do brussels january\""
      ]
     },
     "execution_count": 14,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "clean_txt[0]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "id": "abf066d5",
   "metadata": {},
   "outputs": [],
   "source": [
    "# bigram vectorization\n",
    "\n",
    "vectorizer_n_gram = TfidfVectorizer(ngram_range = (1,1)) # BI-GRAMS\n",
    "cleaned_vectorizer_n_gram = vectorizer_n_gram.fit_transform(clean_txt)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "db1ed1a3",
   "metadata": {},
   "outputs": [],
   "source": [
    "# function for integration to .py file later\n",
    "# def vectorizer(clean_txt):\n",
    "#     vectorizer_n_gram = TfidfVectorizer(ngram_range = (1,1)) # BI-GRAMS\n",
    "#     cleaned_vectorizer_n_gram = vectorizer_n_gram.fit_transform(clean_txt)\n",
    "#     return cleaned_vectorizer_n_gram"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 12,
   "id": "bcf39f21",
   "metadata": {},
   "outputs": [],
   "source": [
    "df = pd.DataFrame(cleaned_vectorizer_n_gram.toarray(), columns=vectorizer_n_gram.get_feature_names_out())"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3 (ipykernel)",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.8.13"
  },
  "toc": {
   "base_numbering": 1,
   "nav_menu": {},
   "number_sections": true,
   "sideBar": true,
   "skip_h1_title": false,
   "title_cell": "Table of Contents",
   "title_sidebar": "Contents",
   "toc_cell": false,
   "toc_position": {},
   "toc_section_display": true,
   "toc_window_display": false
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
